202475-55-6Relevant academic research and scientific papers
Quinazoline formulations and therapeutic use thereof
-
, (2008/06/13)
Pharmaceutical compositions for parenteral administration of poorly soluble quinazoline compounds in the form of microemulsions or micellar solutions are described. The compositions are useful in treating patients suffering from cancer or having allergic
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
-
, (2008/06/13)
Compounds of the formula: wherein: Rais iodo, (C1-C4)hydroxyalkyl, benzyloxy, OCF3, SCF3, SO3H, SO2F, SO2NR2R3where R2is hydrogen or (
Epidermal growth factor receptor binding compounds for positron emission tomography
-
, (2008/06/13)
A radiolabeled compound of a formula: is described. R1 and R2 are each independently selected from the group consisting of hydrogen, alkyl, hydroxy, alkoxy, halo, haloalkyl, carboxy, carbalkoxy and salts thereof; and A, B, C and D are each independently s
